Skip to main navigation Skip to search Skip to main content

Management of intractable back pain from caudal ependymoma with spinal methylprednisolone, bupivacaine and morphine

  • Mark J. Lema
  • , Joseph A. Shady
  • , John G. Zoll
  • , Charles R. West
  • University of Rochester
  • Roswell Park Cancer Institute

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

We report the successful management of severe, intractable low back pain in a 21-year-old female with an ependymoma of the cauda equina using intermittent intrathecal methylprednisolone (20 mg), bupivacaine (2.5 mg) and morphine (1 mg) injections over a 2-year period.

Original languageEnglish
Pages (from-to)245-248
Number of pages4
JournalPain
Volume48
Issue number2
DOIs
StatePublished - Feb 1992

Keywords

  • Bupivacaine
  • Chronic back pain
  • Intrathecal methylprednisolone
  • Morphine
  • Myxopapillary ependymoma in cauda equina
  • Spinal analgesia

Fingerprint

Dive into the research topics of 'Management of intractable back pain from caudal ependymoma with spinal methylprednisolone, bupivacaine and morphine'. Together they form a unique fingerprint.

Cite this